THE RED CAMELLIA

Red camellia, the key ingredient in N°1 DE CHANEL

The red camellia is a flower unlike any other. Its exceptional resilience enables it to bloom in winter at extreme temperatures, once it has accumulated all the energy it needs to produce flowers. Within its petals, CHANEL Research identified a revitalising active ingredient that boosts cellular vitality to keep skin looking youthful.

THE RESEARCH

Discovering the properties of red camellia ‘The Czar’ extract, which lies at the core of the N°1 DE CHANEL line, is the result of 17 years of research.

Learn more

THE POWER OF RED CAMELLIA

In-depth study into the House's emblematic flower allowed CHANEL Research to reveal extraordinary levels of protocatechuic acid, a molecule belonging to the polyphenol family that is known for its antioxidant properties.

Red camellia extract increases cellular vitality by

(1)In vitro test measuring a specific expression marker, both in untreated cells and cells treated with red camellia extract.

THE CAMELLIA IN ALL ITS FORMS

N°1 DE CHANEL beauty products improve skin's vitality and hydration, and strengthen its protective function. Their formulas contain up to 76% camellia-derived ingredients, including an extract, oil, ceramides, yeast extract and water. A flower with extraordinary powers, showcased in all its forms.

THE N°1 DE CHANEL DIFFERENCE

The N°1 DE CHANEL ritual boosts skin's vitality, improves its elasticity by 25%⁽²⁾ and its radiance by 54%⁽⁴⁾, and leaves it feeling 81%⁽³⁾ more comfortable. It reduces the appearance of wrinkles by 25%⁽¹⁾ and the visibility of pores by 25%⁽²⁾.

noticeably radiant skin⁽⁴⁾
diminished wrinkles⁽¹⁾

*Products used: the N°1 DE CHANEL lotion, N°1 DE CHANEL eye cream, N°1 DE CHANEL serum, N°1 DE CHANEL cream, N°1 DE CHANEL foundation, and N°1 DE CHANEL serum-in-mist.
(1)Clinical evaluation after 2 months of use, 45 women in a polluted environment.
(2)Clinical evaluation after 1 month of use, 45 women in a polluted environment.
(3)Self-assessment completed immediately after use, 45 women.
(4)Clinical evaluation immediately after use, 45 women in a polluted environment.